Skip to main content

MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclsoure

17 Dec 2025 Evaluate

Oxygenta Pharmaceutical has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1769.40
Dr. Reddys Labs. 1354.80
Cipla 1378.50
Lupin 2002.80
Zydus Lifesciences 1235.95
View more..